Selected research
Market Outlook & Growth Opportunities
Global External Preparation Technology Platform Market Outlook and Growth Opportunities 2026
Market perspective
The global External Preparation Technology Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for External Preparation Technology Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for External Preparation Technology Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for External Preparation Technology Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the External Preparation Technology Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the External Preparation Technology Platform market include Johnson and Johnson, GlaxoSmithKline plc, Novartis International AG, Bayer AG, Pfizer Inc., Sanofi S.A., Roche Holding AG, Merck and Co., Inc. and Procter and Gamble Co., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global External Preparation Technology Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of External Preparation Technology Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents External Preparation Technology Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global External Preparation Technology Platform market.
External Preparation Technology Platform Segment by Company
Johnson and Johnson
GlaxoSmithKline plc
Novartis International AG
Bayer AG
Pfizer Inc.
Sanofi S.A.
Roche Holding AG
Merck and Co., Inc.
Procter and Gamble Co.
3M Company
Teva Pharmaceutical Industries Ltd.
Leo Pharma A/S
Mylan N.V.
Sun Pharmaceutical Industries Ltd.
Beiersdorf AG
External Preparation Technology Platform Segment by Type
Ointment
Gel
Spray
Patch
Lotion
External Preparation Technology Platform Segment by Application
Skin Disease
Arthritis
Pain Management
Wound Healing
Other
External Preparation Technology Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global External Preparation Technology Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the External Preparation Technology Platform key companies, revenue, market share, and recent developments.
3. To split the External Preparation Technology Platform breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions External Preparation Technology Platform market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify External Preparation Technology Platform significant trends, drivers, influence factors in global and regions.
6. To analyze External Preparation Technology Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global External Preparation Technology Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of External Preparation Technology Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of External Preparation Technology Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global External Preparation Technology Platform industry.
Chapter 3: Detailed analysis of External Preparation Technology Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of External Preparation Technology Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of External Preparation Technology Platform in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Ointment
- Gel
- Spray
- Patch
- Lotion
Applications
- Skin Disease
- Arthritis
- Pain Management
- Wound Healing
- Other
Companies covered
- Johnson and Johnson
- GlaxoSmithKline plc
- Novartis International AG
- Bayer AG
- Pfizer Inc.
- Sanofi S.A.
- Roche Holding AG
- Merck and Co., Inc.
- Procter and Gamble Co.
- 3M Company
- Teva Pharmaceutical Industries Ltd.
- Leo Pharma A/S
- Mylan N.V.
- Sun Pharmaceutical Industries Ltd.
- Beiersdorf AG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global External Preparation Technology Platform Market Size, 2021 VS 2025 VS 2032
- 1.3 Global External Preparation Technology Platform Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 External Preparation Technology Platform Market Dynamics
- 2.1 External Preparation Technology Platform Industry Trends
- 2.2 External Preparation Technology Platform Industry Drivers
- 2.3 External Preparation Technology Platform Industry Opportunities and Challenges
- 2.4 External Preparation Technology Platform Industry Restraints
3 External Preparation Technology Platform Market by Company
- 3.1 Global External Preparation Technology Platform Company Revenue Ranking in 2025
- 3.2 Global External Preparation Technology Platform Revenue by Company (2021-2026)
- 3.3 Global External Preparation Technology Platform Company Ranking (2024-2026)
- 3.4 Global External Preparation Technology Platform Company Manufacturing Base and Headquarters
- 3.5 Global External Preparation Technology Platform Company Product Type and Application
- 3.6 Global External Preparation Technology Platform Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global External Preparation Technology Platform Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 External Preparation Technology Platform Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 External Preparation Technology Platform Market by Type
- 4.1 External Preparation Technology Platform Type Introduction
- 4.1.1 Ointment
- 4.1.2 Gel
- 4.1.3 Spray
- 4.1.4 Patch
- 4.1.5 Lotion
- 4.2 Global External Preparation Technology Platform Sales Value by Type
- 4.2.1 Global External Preparation Technology Platform Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global External Preparation Technology Platform Sales Value by Type (2021-2032)
- 4.2.3 Global External Preparation Technology Platform Sales Value Share by Type (2021-2032)
5 External Preparation Technology Platform Market by Application
- 5.1 External Preparation Technology Platform Application Introduction
- 5.1.1 Skin Disease
- 5.1.2 Arthritis
- 5.1.3 Pain Management
- 5.1.4 Wound Healing
- 5.1.5 Other
- 5.2 Global External Preparation Technology Platform Sales Value by Application
- 5.2.1 Global External Preparation Technology Platform Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global External Preparation Technology Platform Sales Value by Application (2021-2032)
- 5.2.3 Global External Preparation Technology Platform Sales Value Share by Application (2021-2032)
6 External Preparation Technology Platform Regional Value Analysis
- 6.1 Global External Preparation Technology Platform Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global External Preparation Technology Platform Sales Value by Region (2021-2032)
- 6.2.1 Global External Preparation Technology Platform Sales Value by Region: 2021-2026
- 6.2.2 Global External Preparation Technology Platform Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America External Preparation Technology Platform Sales Value (2021-2032)
- 6.3.2 North America External Preparation Technology Platform Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe External Preparation Technology Platform Sales Value (2021-2032)
- 6.4.2 Europe External Preparation Technology Platform Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific External Preparation Technology Platform Sales Value (2021-2032)
- 6.5.2 Asia-Pacific External Preparation Technology Platform Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America External Preparation Technology Platform Sales Value (2021-2032)
- 6.6.2 South America External Preparation Technology Platform Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa External Preparation Technology Platform Sales Value (2021-2032)
- 6.7.2 Middle East & Africa External Preparation Technology Platform Sales Value Share by Country, 2025 VS 2032
7 External Preparation Technology Platform Country-level Value Analysis
- 7.1 Global External Preparation Technology Platform Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global External Preparation Technology Platform Sales Value by Country (2021-2032)
- 7.2.1 Global External Preparation Technology Platform Sales Value by Country (2021-2026)
- 7.2.2 Global External Preparation Technology Platform Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.3.2 USA External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.7.2 France External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.14.2 China External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.17.2 India External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt External Preparation Technology Platform Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt External Preparation Technology Platform Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt External Preparation Technology Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Johnson and Johnson
- 8.1.1 Johnson and Johnson Company Information
- 8.1.2 Johnson and Johnson Business Overview
- 8.1.3 Johnson and Johnson External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.1.4 Johnson and Johnson External Preparation Technology Platform Product Portfolio
- 8.1.5 Johnson and Johnson Recent Developments
- 8.2 GlaxoSmithKline plc
- 8.2.1 GlaxoSmithKline plc Company Information
- 8.2.2 GlaxoSmithKline plc Business Overview
- 8.2.3 GlaxoSmithKline plc External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.2.4 GlaxoSmithKline plc External Preparation Technology Platform Product Portfolio
- 8.2.5 GlaxoSmithKline plc Recent Developments
- 8.3 Novartis International AG
- 8.3.1 Novartis International AG Company Information
- 8.3.2 Novartis International AG Business Overview
- 8.3.3 Novartis International AG External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.3.4 Novartis International AG External Preparation Technology Platform Product Portfolio
- 8.3.5 Novartis International AG Recent Developments
- 8.4 Bayer AG
- 8.4.1 Bayer AG Company Information
- 8.4.2 Bayer AG Business Overview
- 8.4.3 Bayer AG External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.4.4 Bayer AG External Preparation Technology Platform Product Portfolio
- 8.4.5 Bayer AG Recent Developments
- 8.5 Pfizer Inc.
- 8.5.1 Pfizer Inc. Company Information
- 8.5.2 Pfizer Inc. Business Overview
- 8.5.3 Pfizer Inc. External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer Inc. External Preparation Technology Platform Product Portfolio
- 8.5.5 Pfizer Inc. Recent Developments
- 8.6 Sanofi S.A.
- 8.6.1 Sanofi S.A. Company Information
- 8.6.2 Sanofi S.A. Business Overview
- 8.6.3 Sanofi S.A. External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.6.4 Sanofi S.A. External Preparation Technology Platform Product Portfolio
- 8.6.5 Sanofi S.A. Recent Developments
- 8.7 Roche Holding AG
- 8.7.1 Roche Holding AG Company Information
- 8.7.2 Roche Holding AG Business Overview
- 8.7.3 Roche Holding AG External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.7.4 Roche Holding AG External Preparation Technology Platform Product Portfolio
- 8.7.5 Roche Holding AG Recent Developments
- 8.8 Merck and Co., Inc.
- 8.8.1 Merck and Co., Inc. Company Information
- 8.8.2 Merck and Co., Inc. Business Overview
- 8.8.3 Merck and Co., Inc. External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.8.4 Merck and Co., Inc. External Preparation Technology Platform Product Portfolio
- 8.8.5 Merck and Co., Inc. Recent Developments
- 8.9 Procter and Gamble Co.
- 8.9.1 Procter and Gamble Co. Company Information
- 8.9.2 Procter and Gamble Co. Business Overview
- 8.9.3 Procter and Gamble Co. External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.9.4 Procter and Gamble Co. External Preparation Technology Platform Product Portfolio
- 8.9.5 Procter and Gamble Co. Recent Developments
- 8.10 3M Company
- 8.10.1 3M Company Company Information
- 8.10.2 3M Company Business Overview
- 8.10.3 3M Company External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.10.4 3M Company External Preparation Technology Platform Product Portfolio
- 8.10.5 3M Company Recent Developments
- 8.11 Teva Pharmaceutical Industries Ltd.
- 8.11.1 Teva Pharmaceutical Industries Ltd. Company Information
- 8.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
- 8.11.3 Teva Pharmaceutical Industries Ltd. External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.11.4 Teva Pharmaceutical Industries Ltd. External Preparation Technology Platform Product Portfolio
- 8.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
- 8.12 Leo Pharma A/S
- 8.12.1 Leo Pharma A/S Company Information
- 8.12.2 Leo Pharma A/S Business Overview
- 8.12.3 Leo Pharma A/S External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.12.4 Leo Pharma A/S External Preparation Technology Platform Product Portfolio
- 8.12.5 Leo Pharma A/S Recent Developments
- 8.13 Mylan N.V.
- 8.13.1 Mylan N.V. Company Information
- 8.13.2 Mylan N.V. Business Overview
- 8.13.3 Mylan N.V. External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.13.4 Mylan N.V. External Preparation Technology Platform Product Portfolio
- 8.13.5 Mylan N.V. Recent Developments
- 8.14 Sun Pharmaceutical Industries Ltd.
- 8.14.1 Sun Pharmaceutical Industries Ltd. Company Information
- 8.14.2 Sun Pharmaceutical Industries Ltd. Business Overview
- 8.14.3 Sun Pharmaceutical Industries Ltd. External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.14.4 Sun Pharmaceutical Industries Ltd. External Preparation Technology Platform Product Portfolio
- 8.14.5 Sun Pharmaceutical Industries Ltd. Recent Developments
- 8.15 Beiersdorf AG
- 8.15.1 Beiersdorf AG Company Information
- 8.15.2 Beiersdorf AG Business Overview
- 8.15.3 Beiersdorf AG External Preparation Technology Platform Revenue and Gross Margin (2021-2026)
- 8.15.4 Beiersdorf AG External Preparation Technology Platform Product Portfolio
- 8.15.5 Beiersdorf AG Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst